By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
Zydus Pharmaceuticals, Inc., USA et al. v. Teva Pharmaceutical Industries Ltd et al.
1:08-cv-01071; filed October 14, 2008 in the Eastern District of Virginia
Declaratory judgment of non-infringement, invalidity, and unenforceability of U.S. Patent Nos. 6,750,341 ("Preparation of Risperidone," issued June 15, 2005) and 7,256,195 (same title, issued August 14, 2007) based on Zydus' manufacture and sale of risperidone API and risperidone tablets (used to treat schizophrenia). View the complaint here.
AstraZeneca AB et al. v. Ivax Corp. et al.
3:08-cv-04993; filed October 9, 2008 in the District Court of New Jersey
Infringement of U.S. Patent No. 7,411,070 ("Form of S-omeprazole," issued August 12, 2008) following a Paragraph IV certification as part of Ivax's filing of an ANDA to manufacture a generic version of AstraZeneca's Nexium® (esomeprazole magnesium, used for the treatment of gastroesophageal reflux disease). View the complaint here.
Comments